These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 816365

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of a combination of raubasine, dihydroergocristine and dihydroergotamine in dogs and human beings.
    Marzo A, Ghirardi P, Parenti MA, Merlo L, Marchetti G, Cavalca L, Omboni E, Pignataro T, Ligresti A.
    Farmaco Prat; 1981 Apr; 36(4):173-97. PubMed ID: 6785104
    [No Abstract] [Full Text] [Related]

  • 3. [Observations during ambulatory therapy of functional and organic circulatory disorders with Defluina].
    Brüning G.
    Med Welt; 1975 Sep 19; 26(38):1737-41. PubMed ID: 810634
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Alpha-blocking activity of raubasine-dihydroergocristine combination in the demedullated rat].
    Roquebert J, Gomond P, Demichel P.
    Ann Pharm Fr; 1983 Sep 19; 41(1):69-75. PubMed ID: 6137989
    [No Abstract] [Full Text] [Related]

  • 11. Dihydroergotamine: pharmacokinetics, pharmacodynamics, and mechanism of venoconstrictor action in beagle dogs.
    Müller-Schweinitzer E, Rosenthaler J.
    J Cardiovasc Pharmacol; 1987 Jun 19; 9(6):686-93. PubMed ID: 2442535
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effects of raubasine and dihydroergocristine on an age-related deficit in passive avoidance learning in rats.
    Chopin P, Briley M.
    J Pharm Pharmacol; 1990 May 19; 42(5):375-6. PubMed ID: 1976794
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Bioavailability of ergoloid mesylates liquid capsule.
    Schran HF.
    Clin Ther; 1985 May 19; 8(1):71-5. PubMed ID: 3833371
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.